 Home > Active Ingredient News > Antitumor Therapy > JCO: The effect of adjuvant chemotherapy on the quality of life of elderly patients with HER2-positive breast cancer

JCO: The effect of adjuvant chemotherapy on the quality of life of elderly patients with HER2-positive breast cancer

 Last Update: 2021-04-17
 Source: Internet
 Author: User

Tags

qa quality assurance

prozac anxiety

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Breast cancer (BC) overexpressing human epidermal growth factor receptor 2 (HER2 ) has an aggressive clinical course.

Breast cancer

This article reports the results of a study on the quality of life (QoL) of elderly patients with HER2-positive breast cancer.

After surgery, 70-80 years old, HER2-positive breast cancer patients were randomly assigned to trastuzumab (T) group and trastuzumab combined chemotherapy group (T+C).

Overall quality of life comparison

Among 275 patients, 231 (84%) (average age 74) were included in the analysis.

Compared with the T+C group, patients in the T group experienced deterioration in their quality of life at 2 months of treatment (31% vs 48%; p=0.

At 36 months, there were no significant differences in any quality of life assessment items.

In summary, the adverse effects of adjuvant chemotherapy on the overall quality of life, morale and mobility of elderly patients with breast cancer lasted for at least 12 months, but were not observed at 36 months .

The adverse effects of adjuvant chemotherapy on the overall quality of life, morale and mobility of elderly patients with breast cancer lasted for at least 12 months, but were not observed at 36 months

Original source:

Taira Naruto, Sawaki Masataka, Uemura Yukari et al.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.